Books by Subject


  • 2011From: ProQuest Ebook Central
    Mead Over.
    The global AIDS transition: a feasible objective for AIDS policy -- Using incentives to prevent HIV infections -- Sustaining and leveraging AIDS treatment -- Appendix A. Alternative approaches to estimating the average cost of antiretroviral treatment -- Appendix B. A meta-analysis of the health benefits of early initiation of antiretroviral therapy -- Appendix C. A model for projecting future AIDS treatment costs.
  • 2013From: Springer
    Eric O. Freed, editor.
    Over the past decade, enormous progress has been made in understanding the late events in the HIV replication cycle. This has been made possible by major advances in cell biology, virology, and structural biology. The field continues to move forward rapidly, with important new discoveries being reported on a regular basis. The impact of this progress across a broad spectrum of biomedical research has been substantial. The increase in basic knowledge in the areas of HIV assembly, release, and maturation has been accompanied by new possibilities for therapeutic intervention.The work includes topics relating to basic molecular biology, cell biology, and structural biology of HIV assembly, coupled with more applied ideas of how this basic information can inform the field of antiretroviral research. The book covers all major topics pertaining to the late stages of HIV replication, with leaders in each area recruited to contribute chapters in their areas of expertise . The topics will be sufficiently focused to allow authors the opportunity to cover the latest developments in detail.
  • 2010From: Springer
    Donna Hubbard McCree, Kenneth Terrill Jones, Ann O'Leary, editors.
    The HIV/AIDS epidemic is burgeoning among African American men and women. Despite comprising only 13 percent of the population, 50 percent of new HIV diagnoses in 2004 were among African Americans. Among women and men who have sex with men (MSM), African Americans are grossly disproportionately affected by this epidemic, and this trend shows no sign of abating. This book seeks to explore some of the contextual factors that contribute to this disparity as well as ways to intervene to slow the growth of the epidemic in the U.S. This volume will focus on the history and context of HIV/AIDS in African Americans and interventions targeting specific subpopulations including adolescents, heterosexual men and women, men who have sex with men, incarcerated populations, and injection drug users. Context chapters will focus on specific contextual and structural issues related to HIV/AIDS transmission and prevention in African Americans including disparities in incarceration, racism, economic issues and substance abuse. Intervention chapters will focus on best-evidence and promising-evidence based interventions targeting HIV prevention in African Americans. These chapters will address the latest in intervention strategies, program evaluation, cost effectiveness and qualitative research methods and will include risk reduction, risk assessment, and testing and counseling.
  • 2007From: Springer
    edited by C. Meyers.
    Also available: Print – 2007
  • Victoria A. Harden.
    PrintStatus: Not Checked OutLane Catalog Record
    Society was not prepared in 1981 for the appearance of a new infectious disease, but we have since learned that emerging and reemerging diseases will continue to challenge humanity. This work is the first history of HIV/AIDS written for a general audience that emphasizes the medical response to the epidemic. The author, a medical historian approaches the AIDS virus from philosophical and intellectual perspectives in the history of medical science, discussing the process of scientific discovery, scientific evidence, and how laboratories found the cause of AIDS and developed therapeutic interventions. Furthermore, her book places AIDS as the first infectious disease to be recognized simultaneously worldwide as a single phenomenon. After years of believing that vaccines and antibiotics would keep deadly epidemics away, researchers, doctors, patients, and the public were forced to abandon the arrogant assumption that they had conquered infectious diseases. By presenting a discussion of the history of HIV/AIDS and analyzing how aspects of society advanced or hindered the response to the disease, the book illustrates how medicine identifies and evaluates new infectious diseases quickly and what political and cultural factors limit the medical community's response.
  • 2015From: ProQuest Ebook Central
    Peter Piot ; translated by Laurence Garey.
    Peter Piot, founding executive director of the Joint United Nations Programme on HIV/AIDS (UNAIDS), recounts his experience as a clinician, scientist, and activist fighting the disease from its earliest manifestation to today. The AIDS pandemic was not only catastrophic to the health of millions worldwide but also fractured international relations, global access to new technologies, and public health policies in nations across the globe. As he struggled to get ahead of the disease, Piot found science does little good when it operates independently of politics and economics, and politics is worthless if it rejects scientific evidence and respect for human rights. Piot describes how the epidemic altered global attitudes toward sexuality, the character of the doctor-patient relationship, the influence of civil society in international relations, and traditional partisan divides. AIDS thrust health into national and international politics where, he argues, it rightly belongs. The global reaction to AIDS over the past decade is the positive result of this partnership, showing what can be achieved when science, politics, and policy converge on the ground. Yet it remains a fragile achievement, and Piot warns against complacency and the consequences of reduced investments. He refuses to accept a world in which high levels of HIV infection are the norm. Instead, he explains how to continue to reduce the incidence of the disease to minute levels through both prevention and treatment, until a vaccine is discovered. -- Publisher description.
  • 2012From: ProQuest Ebook Central
    Nicoli Nattrass.
    The conspiratorial move against HIV science and its consequences -- AIDS origin conspiracy theories in the United States and South Africa -- Who believes AIDS conspiracy theories and why leadership matters -- Science, politics, and credibility : David Gilbert fights AIDS conspiracy beliefs in US prisons -- Science, conspiracy theory, and the South African AIDS policy tragedy -- Hero scientists, cultropreneurs, living icons, and praise-singers : AIDS denialism as community -- Defending the imprimatur of science : Duesberg and the medical hypotheses saga -- The conspiratorial move and the struggle for evidence-based medicine.
  • 2008From: ClinicalKey
    [edited by] Raphael Dolin, Henry Masur, Michael S. Saag.
    AIDS treatments continues to evolve. Now, so does the definitive reference on this complex and challenging subject. "AIDS Therapy, 3rd Edition" not only brings you comprehensive guidance on the latest treatments for HIV/AIDS and the full range of related disorders and syndromes, but also comes with access to updates online--so you can always tap into the most current therapy guidelines. Written by a "who's who" of leading global experts, the new edition of this classic reference is a must for any clinician who manages patients with HIV/AIDS. The most comprehensive coverage available on AIDS treatment equips you to meet any clinical challenge. Contributions from a large cast of noted international authorities put global "best practices" at your fingertips. Advice from some of the most respected experts in the field helps you manage your patients confidently.
  • 2014From: Springer
    AKM Ahsan Ullah, Ahmed Shafiqul Huque.
    This book explores a number of issues related to the stigma arising from HIV/AIDS infection, perceived or actual discrimination from the community and society, and the extent of vulnerabilities for infected Asian refugees and immigrants. It assesses the health care and treatment regimen for HIV/AIDS accessed by immigrants and refugee claimants in North America, including treatments offered by the health-care system and ethnic communities, and their perceptions and biases relating to HIV/AIDS issues. On another level, the book identifies the ways in which HIV-sufferer immigrants and refugees/refugee claimants from Asia are vulnerable to discrimination due to 1) lack of information about HIV/AIDS incidence in the community; 2) inability of the health system to respond appropriately; and 3) the community{u2019}s need for introspection on their own health issues. This book reveals the dynamics that influence choice, behavior, and lifestyle of HIV sufferer immigrants, adds to the existing knowledge about refugees and migrants, and proposes a unified theory of discrimination and stigmatization within the context of human rights. In addition, the book presents a number of policy recommendations based on empirical findings with a view to helping reshape polices regarding refugee HIV sufferers and their social ramifications. This book will be of interest to researchers and students in any field from social sciences, health and psychology, as well as practitioners in the field of development and public policy. The book will be beneficial to policy formulators and implementers engaged in addressing the serious threat emanating from the HIV/AIDS pandemic.
  • Jennifer Kates, Rachel Garfield, Katherine Young, Kelly Quinn, Emma Frazier, Jacek Skarbinsk.
    This issue brief, based on analysis of nationally representative data from the Center s for Disease Control and Prevention's (CDC's ) Medical Monitoring Project (MMP), provides the first such estimates, looking at how many uninsured people with HIV in care could gain new Medicaid coverage, as well as how many could be eligible for subsidized coverage in state Marketplaces. We estimate the impact of state decisions about expanding Medicaid on the reach of the ACA for people with HIV. We also discuss the current and estimated future role of the Ryan White HIV/AIDS Program, which provides care to people with HIV who are uninsured or underinsured. Finally, while our analysis focuses on those who are already in regular care (an estimated 37% of all people living with HIV in the United States, or 45% of those who have been diagnosed with HIV), we also discuss the implications of the ACA for the m ore than 700,000 people with HIV who remain either undiagnosed or not in regular HIV care.
  • 2010(published 2013)
    All case data presented on the maps were reported to the San Francisco Department of Public Health HIV Epidemiology Section as of January 5, 2012. Population data for calculating the rates of living HIV/AIDS cases and new HIV diagnoses were obtained from the 2010 Census.
  • 2010From: ClinicalKey
    edited by Stephen Morse [and others].
    Genital and Dermatologic Examination -- Gonorrhea -- Infections Caused by Chlamydia Trachomatis -- Genital Mycoplasmas -- Vaginal Infections -- Pelvic Inflammatory Disease -- Syphilis -- Chancroid -- Chancroid -- Genital Herpes -- Genital Human Papillomavirus Infections -- Viral Hepatitis -- Human Immunodeficiency Virus Infection and the Acquired Immunodeficiency Syndrome : Epidemiology -- Human Immunodeficiency Virus Infection and the Acquired Immunodeficiency Syndrome : Viral Pathogenesis, Laboratory Diagnosis and Monitoring -- Human Immunodeficiency Virus Infection and the Acquired Immunodeficiency Syndrome : Diagnosis and Management -- Sexually Transmissible Infections in Infants, Children and Adolescents -- Infestations -- Syndromic Management -- Appendix 1 The Laboratory Diagnosis of STDs - Principles, Selection, and Evaluation of Diagnostic Tests -- Appendix 2 Media, Stains, Reagents and Test Procedures.
  • 2013From: Springer
    Rachel E. Golden, Charles B. Collins, Shayna D. Cunningham, Emily N. Newman, Josefina J. Card.
    Introduction -- Overview of Structural Interventions to Decrease Injection Drug-Use Risk -- Overview of Structural Interventions to Decrease Noncommercial Sex Risk -- Overview of Structural Interventions to Decrease Commercial Sex Risk -- Overview of Structural Interventions to Increase Voluntary Counseling and Testing (VCT) and Antiretroviral Therapy (ART) -- Conclusion.
  • 2007From: Springer
    edited by Sandra Gessani, Filippo Belardelli.
    General aspects of dendritic cell biology, functions, and clinical application. -- Dendritic cell biology: subset heterogeneity and functional plasticity / Vassili Soumelis, Yong-Jun Liu, and Michel Gilliet -- Dendritic cells and their role in linking innate and adaptive immune responses / Mary F. Lipscomb, Julie A. Wilder, and Barbara J. Masten -- Dendritic cell and pathogen interactions in the subversion of protective immunity / John E. Connolly, Damien Chaussabel, and Jacques Banchereau -- Dendritic cells as keepers of peripheral tolerance / Sabine Ring, Alexander H. Enk, and Karsten Mahnke -- Adjuvants, dendritic cells, and cytokines: strategies for enhancing vaccine efficacy / Paola Rizza, Imerio Capone, and Filippo Belardelli -- Ex vivo-generated dendritic cells for clinical trials versus in vivo targeting to dendritic cells: critical issues / Joannes F.M. Jacobs ... [et al.] -- General aspects of the pathogenesis and immune response to HIV-1 infection. -- Immunopathogenesis of HIV infection / Elisa Vicenzi ... [et al.] -- Innate cellular immune responses in HIV infection / Barbara Schmidt ... [et al.] -- Adaptive immune responses in HIV-1 infection / Mara Biasin and Mario Clerici -- Dendritic cells and HIV interactions and their role in pathogenesis and immunity. -- Binding and uptake of HIV by dendritic cells and transfer to T lymphocytes: implications for pathogenesis / Anthony L. Cunningham ... [et al.] -- Loss, infection, and dysfunction of dendritic cells in HIV infection / Steven Patterson, Heather Donaghy, and Peter Kelleher -- HIV exploitation of DC biology to subvert the host immune response / Manuela Del Cornò ... [et al.] -- Cross-presentation by dendritic cells: role in HIV immunity and pathogenesis / Concepción Marañón ... [et al.] -- Immunotherapy of HIV infection: dendritic cells as targets and tools / Imerio Capone ... [et al.].
  • 2014From: Springer
    Lisa A. Eaton, Seth C. Kalichman, editors.
    Three decades into the epidemic, a great deal is known about HIV and its transmission, more people are living with the disease, and the virus is no longer seen as a death sentence. But new people continue to be infected with HIV each year, making prevention strategies that are medically effective and behaviorally engaging as urgent a priority as ever. Biomedical Advances in HIV Prevention: Social and Behavioral Perspectives assembles the latest improvements, barriers to implementation, and possibilities for--and challenges to--future progress. Innovations such as pre-exposure prophylaxis (antiretroviral regimens for the high-risk uninfected) and treatment as prevention (early use of ART to reduce infectiousness of new patients) are examined, as are current findings on ongoing prevention and treatment concerns. Contributors illuminate the complex realities entailing adherence, pointing out technological, behavioral, and cultural roadblocks as well as opportunities to significantly reduce infection rates.
  • 2004Limited to 1 simultaneous usersFrom: ProQuest Ebook Central
    Susan S. Hunter.
    Also available: Print – 2003
  • 2009From: Springer
    Giuseppe Barbaro, Franck Boccara, (eds.) ; in cooperation with Giorgio Barbarini.
  • 2007From: Springer
    Sana Loue, Earl C. Pike.
  • 2006From: CRCnetBASE
    edited by Andrew D. Badley.
    Also available: Print – 2006
  • 2013From: Springer
    I. W. Fong, editor.
    "This new volume ... aims to address demands and challenges that various infections present to the world at large ('global challenges'), such as the HIV pandemic, continuous threat of spreading common multiresistant pathogenic bacteria, multidrug and extensive drug-resistant tuberculosis, and the influence we can expect on these epidemics with global climate change and international urbanization ... Chapters on these various topics authored by world-renowned experts on these areas provide state-of-the-art reviews on epidemiology, biology, clinical aspects, prevention, current approaches to control, and prevention such as new vaccines, and reassessment of past and present methods are discussed"--Preface.
  • 2010From: Springer
    Olimpia Meucci, editor.
  • 2016From: Wiley
    edited by Jessica Merlin, Peter A Selwyn, Glenn Treisman, Angela Giovanniello.
    Epidemiology of chronic pain in HIV-infected individuals -- Pathophysiology of chronic pain in individuals with HIV -- Musculoskeletal pain in individuals with HIV -- Headache in individuals with HIV -- HIV and peripheral neuropathy -- Common medical comorbid conditions and chronic pain in HIV -- Psychiatric comorbidities among individuals with HIV and chronic pain -- Comorbid substance use among HIV-infected individuals with chronic pain -- Treatment of chronic pain syndromes in the HIV-infected person -- Potential benefit and harm of prescription opioids in HIV -- Safer opioid prescribing in HIV-infected patients with chronic pain -- Communicating about chronic pain assessment, diagnostic testing, and management in individuals with HIV -- The "difficult patient" with HIV and chronic pain -- HIV-related pain in low and middle-income countries with reference to Sub-Saharan Africa -- Pain at the end of life in individuals with AIDS -- Disparities and barriers in management of chronic pain among vulnerable populations with HIV infection.
  • 2008From: Springer
    Rodrick Wallace, Mindy T. Fullilove.
  • 2008From: ProQuest Ebook Central
    edited by Mary Ann Cohen and Jack M. Gorman.
    Part I. Psychiatric Relevance and Implications of AIDS Psychiatry -- History of AIDS Psychiatry: A Biopsychosocial Approach-Paradigm and Paradox -- HIV/AIDS at 25: History, Epidemiology, Clinical Manifestations, and Treatment -- Psychoneuroimmunology and HIV -- Epidemiology of Psychiatric Disorders Associated with HIV and AIDS -- Sociocultural Factors Influencing the Transmission of HIV/AIDS in the United States: AIDS and the Nation's Prisons -- Part II. Comprehensive AIDS Psychiatric Assessment -- A Biopsychosocial Approach to Psychiatric Consultation in Persons with HIV and AIDS -- Neuropsychological Evaluation -- Part III. Psychiatric Disorders and HIV Infection -- Substance Use Disorders - The Special Role in HIV Transmission -- Mood Disorders -- HIV-Associated Neurocognitive Disorders -- Anxiety Disorders -- Psychotic Disorders and Severe Mental Illness -- The Role of Personality in HIV Risk Behaviors: Implications for Treatment -- Part IV. Unique Psychiatric Manifestations of HIV Infection -- Distress in Persons with HIV and AIDS -- Insomnia and HIV: A Biopsychosocial Approach -- Fatigue and HIV -- Unique Manifestations of HIV-Associated Dementia -- Suicide -- Part V. Neuropathologic Manifestations of HIV Infection -- HIV and the Central Nervous System -- Neurological Complications of HIV in the Spinal Cord and Peripheral Nervous System -- Part VI. Risk Behaviors, HIV Transmission, and Adherence -- The Role of Psychiatric Disorders in HIV Transmission and Prevention -- Psychiatric Aspects of Adherence to Medical Care and Treatment for HIV/AIDS -- Homelessness and HIV Risk and Prevention -- Part VII. AIDS Psychiatry through the Life Cycle -- Childhood and Adolescence -- Young Adulthood and Serodiscordant Couples -- Older Age and HIV Infection -- Part VIII. AIDS Psychiatric Treatment and Psychotherapeutic Modalities -- Psychiatric Interventions -- Social Service Interventions -- Nursing Support -- Palliative and Spiritual Care of Persons with HIV and AIDS -- Special Settings: Psychiatric Facilities, Nursing Homes, Correctional Facilities, and Homeless Outreach -- Psychopharmacologic Treatment Issues in AIDS Psychiatry -- Part IX. AIDS Psychiatry and Comorbid Medical Conditions -- Hepatitis C and HIV Coinfection -- HIV-Associated Nephropathy, End-Stage Renal Disease, Dialysis, and Kidney Transplant -- Endocrine Comorbidities in Persons with HIV -- Lipodystrophy, Metabolic Disorders, and Cardiovascular Disorders in Persons with HIV -- Overview of HIV-Associated Comorbidities -- Part X. Ethical and Health Policy Aspects of AIDS Psychiatry -- Burnout, Occupational Hazards, and Health Care Workers with HIV -- End-of-Life Issues -- Ethical Issues, Advance Directives, and Surrogate Decision-Making -- Health Services and Policy Issues in AIDS Psychiatry.
    Also available: Print – 2008
  • Jessie Lue Juusola.
    Human immunodeficiency virus (HIV) is a significant problem worldwide as well as in the United States (US), despite ongoing efforts to limit HIV transmission. In the US, men who have sex with men (MSM) account for over half of new HIV infections every year, and thus are an important group to consider for HIV interventions. Both prevention and treatment options are available to combat HIV transmission, but decision makers must prioritize among the available disease control strategies. Mathematical modeling frameworks can be used to assess the value and efficiency of various disease control measures and help inform resource allocation decisions. This dissertation describes research on economic analysis of HIV prevention and treatment portfolios, primarily for MSM in the US. We develop two independent mathematical modeling frameworks, both intended to assist decision makers with minimizing HIV transmission in the most cost-effective manner. First, in Chapter 2, we present a dynamic compartmental model of the HIV epidemic that we built and instantiated for MSM in the US. This model can be used to assess the effectiveness and cost-effectiveness of prevention and treatment programs for MSM. In particular, in Chapter 3 we examine testing for and treating acute HIV infection, and in Chapter 4 we examine preexposure prophylaxis for HIV prevention. We find that symptom-based testing for acute HIV infection is cost-effective for MSM in the US, but incorporating testing for acute infection into the standard HIV screening protocol is not. For preexposure prophylaxis, we find that it is not cost-effective for the general MSM population, but it provides good value in high-risk MSM. In Chapter 5, we present a resource allocation framework for determining the optimal mix of HIV treatment and prevention programs, given a fixed budget. We develop methods of linearly estimating health benefits and costs that account for epidemic effects of reducing disease transmission. We illustrate our model with the examples of preexposure prophylaxis and community-based education compared with antiretroviral therapy for MSM in the US. We show both analytically and with the examples that HIV budgets are often best spent on the program that offers the greatest "bang for the buck.".
  • 2007From: Springer
    edited by Jacqueline D. Reeves and Cynthia A. Derdeyn.
  • 2012From: Springer
    Willo Pequegnat, Carl C. Bell, editors.
  • René Bonnel, Rosalía Rodriguez-García, Jill Olivier, Quentin Wodon, Sam McPherson, Kevin Orr and Julia Ross
    In the past decade the global financial assistance for AIDS responses increased tremendously and the donor community provided greater resources to community responses. Yet little is known about the global magnitude of these resources and their allocation among HIV and AIDS activities and services. To address this knowledge gap, this report pulls together evidence from several different sources (donor data bases, surveys of civil society organizations, country funding profiles) to determine, among other things, how funds are reaching civil society and community-based organizations, how these funds are being used, and the degree to which these organizations rely on other sources of funding.--Source other than Library of Congress.
  • 2015From: Springer
    Bruce E. Torbett, David S. Goodsell, Douglas D. Richman, editors.
    This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce viral resistance, and alter the state of viral latency are presented. Experts at the forefront of HIV-1 research provide overviews of approaches from the fields of virology, chemical biology and structural biology for obtaining small molecule inhibitors that target viral regulatory and structural components at multiple points in the viral lifecycle.
  • 2009From: Springer
    Joseph D. Tucker, Dudley L. Posten, editors ; Qiang Ren ... [et al.], co-editors.
    China's concentrated HIV epidemic is on the brink of becoming a generalized one and syphilis infection has become a major public health threat. Social factors relating to gender and gender inequality exacerbate the spread of HIV and sexually transmitted infections (STI) in China. A better understanding of the proximate social determinants of HIV related to gender will be crucial to effectively curbing HIV and other STIs in China. Aspects of China's governance - including administrative procedures, the developing legal system, social institutions, and the public health infrastructure are instrumental in shaping strategies and responses to HIV. International studies suggest that women who are more economically and socially vulnerable may also have a greater risk of HIV infection, yet few initiatives have focused on discrete areas where achievable and sustainable gender policy measures could be linked to the public health response. This study presents perspectives ranging from criminology to social psychology to better understand how gender perspectives can inform HIV policy in the context of China. - Publisher's Description.
  • 2015From: Springer
    Ben Berkhout, Hildegund C.J. Ertl, Marc S. Weinberg, editors.
    Gene therapies for hepatitis C virus / Monique M.A. Verstegen, Qiuwei Pan, and Luc J.W. van der Laan -- Recent advances in use of gene therapy to treat hepatitis B virus infection / Kristie Bloom, Abdullah Ely, and Patrick Arbuthnot -- U1interference (U1i) for antiviral approaches / Lorea Blázquez and Puri Fortes -- Gene therapy strategies to block HIV-1 replication by RNA interference / Elena Herrera-Carrillo and Ben Berkhout -- HIV and ribozymes / Robert J. Scarborough and Anne Gatignol -- Editing CCR5: a novel approach to HIV gene therapy / Tatjana I. Cornu, Claudio Mussolino, Kristie Bloom, and Toni Cathomen -- Synthetic DNA approach to cytomegalovirus vaccine/immune therapy / Stephan J. Wu, Daniel O. Villarreal, Devon J. Shedlock, and David B. Weiner -- Vector-mediated antibody gene transfer for infectious diseases / Bruce C. Schnepp and Philip R. Johnson -- HIV latency and the non-coding RNA therapeutic landscape / Sheena Saayman, Thomas C. Roberts, Kevin V. Morris, and Marc S. Weinberg -- C peptides as entry inhibitors for gene therapy / Lisa Egerer, Hans-Peter Kiem, and Dorothee von Laer -- Aptamer-siRNA chimeras for HIV / Mayumi Takahashi, John C. Burnett, and John J. Rossi -- Index.
    Also available: Print – 2015
  • 2015From: OSO
    2015From: ProQuest Ebook Central
    Myles W. Jackson.
    In The Genealogy of a Gene, Myles Jackson uses the story of the CCR5 gene to investigate the interrelationships among science, technology, and society. Mapping the varied "genealogy" of CCR5 -- intellectual property, natural selection, Big and Small Pharma, human diversity studies, personalized medicine, ancestry studies, and race and genomics -- Jackson links a myriad of diverse topics. The history of CCR5 from the 1990s to the present offers a vivid illustration of how intellectual property law has changed the conduct and content of scientific knowledge, and the social, political, and ethical implications of such a transformation. The CCR5 gene began as a small sequence of DNA, became a patented product of a corporation, and then, when it was found to be an AIDS virus co-receptor with a key role in the immune system, it became part of the biomedical research world -- and a potential moneymaker for the pharmaceutical industry. When it was further discovered that a mutation of the gene found in certain populations conferred near-immunity to the AIDS virus, questions about race and genetics arose. Jackson describes these developments in the context of larger issues, including the rise of "biocapitalism," the patentability of products of nature, the difference between U.S. and European patenting approaches, and the relevance of race and ethnicity to medical research.
  • Deanna Kerrigan, Andrea Wirtz, Stefan Baral, Michele Decker, Laura Murray, Tonia Poteat, Carel Pretorius, Susan Sherman, Mike Sweat, Iris Semini, N'Della N'Jie, Anderson Stanciole, Jenny Butler, Sutayut Osornprasop, Robert Oelrichs, and Chris Beyrer.
    This volume presents an integrated epidemiologic, social, and economic analysis of the global epidemics of HIV among sex workers in low- and middle-income countries. The book provides a comprehensive review and synthesis of the available public health and social science data to characterize the nature, scope, and complexities of these epidemics. A community empowerment-based approach to HIV prevention, treatment, and care is outlined and demonstrated to be cost-effective across multiple settings, with a significant projected impact on HIV incidence among sex workers and transmission dynamics overall. The Global HIV Epidemics among Sex Workers seeks to assist governments, public health implementing agencies, donors, and sex worker communities to better understand and respond to the epidemics among a population facing heightened social and structural vulnerabilities to HIV. The book combines a systematic review of the global epidemiology of HIV among sex workers and in-depth case studies of the epidemiology, policy and programmatic responses and surrounding social contexts for HIV prevention, care and treatment in eight countries. The authors employ mathematical modeling and cost-effectiveness analysis to assess the potential country-level impact of a community empowerment-based approach to HIV prevention, treatment, and care among sex workers when taken to scale in four countries representing diverse sociopolitical contexts and HIV epidemics: Brazil, Kenya, Thailand, and Ukraine. In each setting, greater investment in prevention, treatment, and care for sex workers is shown to significantly reduce HIV. Together these findings underline the urgency of further global investment in comprehensive, human rights-based responses to HIV among sex workers.
  • 2008From: Springer
    Bradly J. Condon, Tapen Sinha.
  • 2008From: Springer
    Sana Loue, editor.
    Defining men who have sex with men (MSM) / Sana Loue -- Portrait one. Rebirth: evolution of a gender / Travis A. Garry -- Portrait two. 5De donde? / Hank Ramirez -- Portrait three. Untitled / Christina Caruth -- Sexual abuse. Childhood sexual abuse and its sequelae among latino gay and bisexual men / Sonya Grant Arreola -- Portrait four. May and December: dangerous intimacies / L. Michael Gipson -- Mental illness and substance abuse. Body image disturbance and its related disorders / Leslie J. Heinberg and Chris Kraft -- Portrait five. Cutting / Anonymous -- Substance use among minority men who have sex with men / Sana Loue and Jaroslaw Richard Romaniuk -- Homelessness. Homelessness among substance using minority men who have sex with men / James M. Holbrook -- "My body and my spirit took care of me": homelessness, violence, and resilience among American Indian two-spirit men / Karina L. Walters ... [et al.] -- National trends in HIV transmission among minority men who have sex with men / Daniel J. O'Shea -- HIV/AIDS in Cleveland: a case study of one community / David Bruckman -- Why tell? Serostatus disclosure and HIV stigma among HIV seropositive Asians and Pacific Islander men who have sex with men in New York City / Ezer Kang and Bruce D. Rapkin -- Disclosure of HIV status and mental health among Latino men who have sex with men / Maria Cecilia Zea -- The Beyond Identities Community Center (BICC): a community-focused, rights-based program to address HIV/AIDS and sexual health among young men of color in Cleveland, Ohio / Tracy Jones and Earl Pike -- Portrait six. For Jayla / L. Michael Gipson -- Portrait seven. Rage of betrayal / Erik Bradford -- Portrait eight. Community commitment / Various.
  • 2017From: Karger
    volume editors, Mark Brennan-Ing, Rosanna F. DeMarco.
    Preface -- Local and global HIV aging demographics and research -- Are HIV-infected older adults aging differently? -- Cellular senescence, immunosenescence and HIV -- Biomarkers and clinical indices of aging with HIV -- Multimorbidity and burden of disease -- Polypharmacy, using new treatments to customize care for aging patients and adherence present and future -- Behavioral health -- Disability among persons aging with HIV/AIDS -- Application of geriatric principles and care models in HIV and aging -- Sexual health, risk and prevention -- Stigma in an aging context -- Social support systems and social network characteristics of older adults with HIV -- Remediating HIV-associated neurocognitive disorders via cognitive training: a perspective on neurocognitive aging -- Mental health, psychosocial challenges and resillence in older adults living with HIV -- Medical, social and supportive services for older adults with HIV -- The relevance of palliative care in HIV and aging -- Ageism, aging, and HIV: community responses to prevention, treatment, care and support -- Author index -- Subject index.
  • 2007From: Springer
    S. Kartikeyan ... [et al.]
  • 2012From: Springer
    Kenneth E. Sherman, editor.
    HIV epidemic in the USA: current trends, 2010 -- Epidemiology of liver disease in human immunodeficiency virus-infected persons -- Current and future treatment guidelines for HIV -- Pathology of HIV-associated liver disease -- Noninvasive markers of liver injury and fibrosis -- Mechanisms of alcoholic steatosis/steatohepatitis -- Immunopathogenesis of liver injury -- Host gene polymorphisms and disease/treatment outcomes in HIV and viral coinfections -- Effects of HIV on liver cell populations -- HIV replication -- Hepatitis C: natural history -- Natural history of hepatitis B virus in HIV-infected patients -- Other hepatitis viruses and HIV infection -- Hepatitis B virus: replication, mutation, and evolution -- Hepatitis C virus treatment in HIV -- Treatment of hepatitis B in HIV-infected persons -- Prevention of hepatitis infection in HIV-infected persons -- Antiretroviral therapy and hepatotoxicity -- Management of end-stage liver disease and the role of liver transplantation in HIV-infected patients -- Assessment and treatment of alcohol- and substance-use disorders in patients with HIV infection -- Racial disparities in HIV and liver disease -- Quality of life in patients with HIV infection and liver disease.
  • 2014From: Wiley
    edited by John A. Joska, Dan J. Stein, Igor Grant.
    Epidemiology of psychopathology in HIV / Milton L. Wainberg, Karen McKinnon and Francine Cournos -- Pathogenesis of mental health disorders in HIV / Gursharan Chana, Chad A. Bousman and Ian P. Everall -- Clinical aspects of HIV-related neurocognitive disorders / Nicholas W.S. Davies and Bruce J. Brew -- Treatment of psychiatric disorders in HIV / Maria Ferrara, Ignacio Perez Valero, David J. Moore, Adam F. Knight, Nichole A. Duarte and J. Hampton Atkinson -- Special populations and public health aspects / Francine Cournos, Karen McKinnon, Veronica Pinho and Milton Wainberg.
  • 2009From: Springer
    edited by Robert H. Paul, Ned Charles Sacktor, Victor Valcour, Karen Tokie Tashima.
    Neurocognitive changes in AIDS: evolution of treatment of HIV infection / Erna Milunka Kojic and Charles C.J. Carpenter -- Global incidence and epidemiology of the AIDS pandemic, distribution of HIV subtypes, and epidemiology of hepatitis C infection among HIV-positive individuals / Karen T. Tashima and Aadia I. Rana -- New insights into HIV neuropathogenesis / Tory P. Johnson and Avindra Nath -- Neuropathological findings associated with long-term HAART / Iain C. Anthony and Jeanne E. Bell -- Biomarkers of HIV-related central nervous system disease / Bruce James Brew and Scott Letendre -- Neuroimaging among HIV-infected patients: current knowledge and future directions / David F. Tate ... [et al.] -- The assessment of HIV-associated neurocognitive disorders: new challenges in the HAART era / Lucette A. Cysique and Bruce J. Brew -- The changing face of HIV-associated cognitive and neuropsychiatric disturbance / Ron Cohen -- Youth with HIV/AIDS: neurobehavioral consequences / Susannah Allison, Pamela L. Wolters, and Pim Brouwers -- Co-occurrence of HIV, hepatitis C, and substance use disorders: effects on brain functioning / Raul Gonzalez, Phillip J. Quartana, and Eileen M. Martin -- The functional impact of HIV-associated neuropsychological decline / Matthew J. Wright ... [et al.] -- Adjunctive therapy for long-term support of cognitive impairment / Joshua T. Dearborn ... [et al.] -- HIV-1 genetic diversity and its biological significance / Michael M. Thomson -- Opportunistic infections in the brain in developing countries / Marcus Tulius T. Silva and Beatriz Grinsztejn -- Impact of Clade diversity on neuropsychological outcomes / Robert Paul ... [et al.] -- The effects of aging on HIV disease / Robert C. Kalayjian and Lena Al-Harthi -- Neuropsychology of healthy aging / Molly E. Zimmerman and Adam M. Brickman -- Interactions between advanced age and HIV cognitive impairment / Victor Valcour and Aaron M. McMurtray.
  • 2016From: Springer
    Gary Jones.
    Revisiting the thinking on vulnerability to HIV and risk of infection, this book provides better understanding by considering the risk of HIV infection alongside notions of personal and collective resilience, dignity and humiliation. The work shows that young people in the urban slum dignify their world and, in doing so, establish priorities and draw on a set of references oftentimes intelligible to them alone. Moreover, humiliation, as an interpersonal event, adds to a sense of vulnerability and lies closely behind choices directly affecting personal health and livelihood. Thus, dignity and humiliation are shown for the first time to have a critical role in health seeking and risky behavior related to HIV, and this is an area in great need of further research. The crucial focus of this work is further emphasized by the rapid growth of urban slums, and high rates of HIV among both slum dwellers and young people, who continue to bear the brunt of the AIDS epidemic, thirty years on. This comprehensive literature review provides a compelling argument that the time is right to further explore the nexus of risk and resilience from a people-centered perspective. Fresh insight is critical to reach the goal of ending AIDS by 2030.
  • 2016From: Springer
    Marcus Hentrich, Stefan K. Barta, editors.
    Pathology -- Epidemiology -- Non-Hodgkin Lymphoma.-Hodgkin lymphoma -- Acute Myeloid Leukemia (AML) & Myelodysplastic Syndrome (MDS) -- Acute lymphoblastic leukemia (ALL) -- Autologous stem cell transplantation -- Allogeneic stem cell transplantation -- Multiple myeloma and monoclonal gammopathy of unknown significance -- Myeloproliferative disorders -- Multicentric Castelman's disease -- Chemotherapy and interactions with combination antiretroviral therapy (cART) -- Special considerations.
  • 2014From: Springer
    Ralph Pantophlet, editor.
    Glycosylation is a common and extremely important modification in biological molecules, particularly of proteins. HIV Glycans in Infection and Immunity provides an overview of the roles of glycans in the transmission/infection, antigenicity, and immunogenicity of HIV and the HIV envelope glycoprotein. It explores recent advances in the understanding of the impact of HIV glycans in infection and their promise for immunological and therapeutic intervention. Novel collaborations between glycobiologists and immunologists in recent years have led to key advances in the understanding of HIV glycans. These cross-disciplinary endeavors, their achievements and their impact on the field are all addressed, herein.-- Source other than Library of Congress.
  • 2013From: Springer
    Li Wu, Olivier Schwartz, editors.
    Also available: Print – 2013
  • 2009From: Springer
    Paul Spearman, Eric O. Freed, editors.
    Preface -- Host restriction of HIV-1 by APOBEC3 and viral evasion through Vif -- Interactions of viral protein U (Vpu) with cellular factors -- TRIM5alpha -- Human immunodeficiency virus type-1 Gag and host vesicular trafficking pathways -- The roles of tetraspanins in HIV-1 replication -- Imaging of HIV/host protein interactions -- Virological and cellular roles of the transcriptional coactivator LEDGF/p75 -- Implications of Nef: host cell interactions in viral persistence and progression to AIDS -- Vpr and its interactions with cellular proteins.
    Also available: Print – 2009
  • 2013From: Future Med
    editors, Marie-Louise Newell, Frank Tanser.
    HIV prevention / Marie-Louise Newell & Frank Tanser -- Diagnosis and promotion of serostatus awareness in sub-Saharan Africa / Ruanne V. Barnabas, Heidi van Rooyen & Connie Celum -- Ask the experts : HIV vertical transmission prevention / Marie-Louise Newell & Claire Thorne -- The ART of pre- and post-exposure prophylaxis / Kevin Brian Rebe & James McIntyre -- Microbicides for HIV prevention : theory and future prospects / Gita Ramjee -- HIV prevention and men: general population and vulnerable subgroups / John Imrie, Geoff Jobson, Jerome Galea & Glenn de Swardt -- Implementation of HIV treatment-as-prevention : resources and behaviors / Till Bärnighausen & François Dabis -- Prevention of sexual transmission of HIV in adolescents / Audrey Pettifor, Molly Rosenberg & Sinead Delany-Moretlwe -- Mathematical modeling of HIV elimination strategies / Jan A.C. Hontelez & Leigh F. Johnson -- Multiple choice questions : answers.
  • 2009From: ScienceDirect
    edited by Kenneth H. Mayer and Hank F. Pizer.
    Current and future trends: implications for HIV preventions / Vikrant V. Sahasrabuddhe and Sten H. Vermund -- Understanding the biology of HIV-1 transmission: the foundation for prevention / Deborah J. Anderson -- HIV vaccines / Robert E. Geise and Ann Duerr -- Microbicides / Ian McGowan -- Using antiretrovirals to prevent HIV transmission / Cynthia L. Gay, Angela D. Kashuba and Myron S. Cohen -- Male circumcision and HIV prevention / Ronald Gray, David Serwadda, Godfrey Kigozi and Maria J. Wawer -- Payoff from AIDS behavioral prevention research / Willo Pequegnat and Ellen Stover -- Individual interventions / Matthew J. Mimiaga ... [et al.] -- Couples' voluntary counseling and testing / Kathy Hageman, Amanda Tichacek and Susan Allen -- Updating HIV prevention with gay men: current challenges and opportunities to advance health among gay men / Ron Stall, Amy Herrick, Thomas E. Guadamuz and Mark S. Friedman -- Reducing sexual risk behavior among men and women with HIV infection / Jean L. Richardson and Tracey E. Wilson -- Injection drug use and HIV: past and future consideration for HIV prevention and interventions / Crystal M. Fuller, Chandra Ford and Abby Rudolph -- HIV risk and prevention for non-injection substance users / Lydia N. Drumright and Grant N. Colfax -- Preventing HIV among sex workers / Bea Vuylsteke, Anjana Das, Gina Dallabetta and Marie Laga -- Interventions with youth in high-prevalence areas / Quarraisha Abdool Karim, Anna Meyer-Weitz and Abigail Harrison -- Interventions with incarcerated persons / Ank Nijhawan, Nickolas Zaller, David Cohen and Josiah D. Rich -- Preventing mother-to-child transmission of HIV / James A. McIntyre and Glenda E. Gray -- Harm reduction, human rights and public health / Christ Beyrer, Susan G. Sherman and Stefan Baral -- HIV testing and counseling / Julie A. Denison, Donna L. Higgins and Michael D. Sweat -- Structural interventions in societal contexts / Suniti Solomon and Kartik K. Venkatesh -- Evaluating HIV/AIDS programs in the US and developing countries / Jane T. Bertrand, David R. Holtgrave and Amy Gregowski -- Adapting successful research studies in the public health arena: going from efficacy trials to effective public health interventions / Kevin A. Fenton, Richard J. Wolitski, Cynthia M. Lyles and Sevgi O. Aral.
  • 2007From: Springer
    edited by Michel Caraël and Judith R. Glynn.
  • 2013From: Springer
    Seth C. Kalichman.
  • 2007From: ScienceDirect
    volume editors, Peter Portegies and Joseph R. Berger.
    Also available: Print – 2007
  • The first cases of what would later become known as AIDS were reported in the United States in June of 1981. Since then, 1.8 million people in the U.S. are estimated to have been infected with HIV, including over 650,000 who have already died and more than 1.1 million estimated to be living with the disease today. The response to the U.S. epidemic has yielded numerous successes, but challenges remain.
  • 2009From: Springer
    edited by Poul Rohleder, Leslie Swartz, Seth C. Kalichman, Leickness C. Simbayi.
  • 2009From: Springer
    Valerie Stone, Bisola Ojikutu, M. Keith Rawlings, Kimberly Y. Simth [sic].
  • 2013From: Springer
    Yichen Lu, Max Essex, Chris Chanyasulkit; editors.
    1. Prevention of HIV Infection in the Absence of a Vaccine -- 2. Study Report on Prevention of Mother to Child Transmission for HIV+ Pregnant Mothers in the Yunnan Province -- 3. Antiretroviral Treatment Compliance in the Wenlou Village of Henan Province: A Case Study in Rural China -- 4. HIV/AIDS Treatment and Control in India and the Millennium Development Goals -- 5. HIV Treatment Scale-Up in Africa: The Impact of Drug Resistance -- 6. A Practical Way to Improve Access to Essential Medicines Against Major Infectious Diseases -- 7. When will most AIDS patients in the world have access to effective antiretroviral therapy?
  • 2013From: Springer
    Stuart LeGrice, Matthias Gotte, editors.
    Development of the First AIDS Drugs: AZT and Other Dideoxynueosides / Robert Yarchoan, Hiroaki Mitsuya -- Part I: Structure and Function of HIV RT. Proviral DNA Synthesis in HIV: Background / Dorota Piekna-Przybylska Ph.D., Robert A. Bambara Ph.D. -- The RNase H Domain: Structure, Function and Mechanism / Marcin Nowotny, Małgorzata Figiel -- Conformational Dynamics of Reverse Transcription / Stuart F. J. LeGrice -- Part II: Mechanism of Action of Approved RT Inhibitors. Nucleoside RT Inhibitors: Structural and Molecular Biology / Gaofei Lu, Antonio J. Acosta-Hoyos, Walter A. Scott -- Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) / Kalyan Das Ph.D., Eddy Arnold Ph.D., Stephen H. Hughes Ph.D. -- Part III: Alternative Strategies to Interfere with the Function of HIV RT. Ribonuclease H Inhibitors: Structural and Molecular Biology / Jason W. Rausch -- Targeting Small Molecules and Peptides to the p66-p51 Reverse Transcriptase Interface / Daouda Abba Moussa, Audrey Agopian, Gilles Divita -- Targeting RT Translocation / Gregory L. Beilhartz, Brian J. Scarth, Matthias Götte -- tRNA Primer Sequestration as an Antiviral Strategy / Christopher P. Jones, Karin Musier-Forsyth -- Part IV: HIV Genetic Variability and the Problem of Drug Resistance. HIV Reverse Transcriptase Fidelity, Clade Diversity, and Acquisition of Drug Resistance / Luis Menéndez-Arias -- APOBECs and Their Role in Proviral DNA Synthesis / John S. Albin, Reuben S. Harris -- Role of RNase H Activity in NRTI/NNRTI Drug Resistance / Gilda Tachedjian B.Sc. (Hons), Ph.D., Nicolas Sluis-Cremer B.Sc. (Hons), Ph.D. -- HIV Population Dynamics / Mary Kearney, John Coffin -- Part V: Prevention and Future Approaches. RT Inhibitors as Microbicides / Jan Balzarini.
  • 2012From: Springer
    Athena P. Kourtis, Marc Bulterys, editors.
    Part 1. Transmission of HIV-1 infection to the infant through breastfeeding -- Breastfeeding and Transmission of HIV-1: Epidemiology and Global Magnitude / Mary Glenn Fowler, Athena P. Kourtis, Jim Aizire, Carolyne Onyango-Makumbi and Marc Bulterys -- Breastfeeding and Transmission of Viruses Other than HIV-1 / Claire L. Townsend, Catherine S. Peckham and Claire Thorne -- Breastfeeding Among HIV-1 Infected Women: Maternal Health Outcomes and Social Repercussions / Elizabeth Stringer and Kate Shearer -- Early Diagnosis of HIV Infection in the Breastfed Infant / Chin-Yih Ou, Susan Fiscus, Dennis Ellenberger, Bharat Parekh and Christine Korhonen, et al. -- Part 2. Mechanisms of HIV-1 transmission through breast milk: Virology -- Virologic Determinants of Breast Milk Transmission of HIV-1 / Susan A. Fiscus and Grace M. Aldrovandi -- HIV-1 Resistance to Antiretroviral Agents: Relevance to Mothers and Infants in the Breastfeeding Setting / Michelle S. McConnell and Paul Palumbo -- Animal Models of HIV Transmission Through Breastfeeding and Pediatric HIV Infection / Koen K. A. Van Rompay and Kartika Jayashankar -- Antiretroviral Pharmacology in Breast Milk / Amanda H. Corbett -- Part 3. Mechanisms of HIV-1 transmission through breast milk: Immunology -- The Immune System of Breast Milk: Antimicrobial and Anti-inflammatory Properties / Philippe Lepage and Philippe Van de Perre -- B Lymphocyte-Derived Humoral Immune Defenses in Breast Milk Transmission of the HIV-1 / Laurent Bélec and Athena P. Kourtis -- Cellular Immunity in Breast Milk: Implications for Postnatal Transmission of HIV-1 to the Infant / Steffanie Sabbaj, Chris C. Ibegbu and Athena P. Kourtis -- Part 4. Prevention of breast milk transmission of HIV-1 -- Antiretroviral Drugs During Breastfeeding for the Prevention of Postnatal Transmission of HIV-1 / Athena P. Kourtis, Isabelle de Vincenzi, Denise J. Jamieson and Marc Bulterys -- Immune Approaches for the Prevention of Breast Milk Transmission of HIV-1 / Barbara Lohman-Payne, Jennifer Slyker and Sarah L. Rowland-Jones -- Non-antiretroviral Approaches to Prevention of Breast Milk Transmission of HIV-1: Exclusive Breastfeeding, Early Weaning, Treatment of Expressed Breast Milk / Jennifer S. Read -- Breast Milk Micronutrients and Mother-to-Child Transmission of HIV-1 / Monal R. Shroff and Eduardo Villamor -- Part 5. Research Implementation and Policy Related to Breastfeeding by HIV-1-Infected Mothers -- Historical Perspective of African-Based Research on HIV-1 Transmission Through Breastfeeding: The Malawi Experience / Taha E. Taha -- Breastfeeding and HIV Infection in China / Christine Korhonen, Liming Wang, Linhong Wang, Serena Fuller and Fang Wang, et al. -- The Role of the President's Emergency Plan for AIDS Relief in Infant and Young Child Feeding Guideline Development and Program Implementation / Michelle R. Adler, Margaret Brewinski, Amie N. Heap and Omotayo Bolu -- HIV-1 and Breastfeeding in the United States / Kristen M. Little, Dale J. Hu and Ken L. Dominguez -- Part 6. DEBATE: Should Women With HIV-1 Infection Breastfeed Their Infants? Balancing the Scientific Evidence, Ethical Issues and Cost-Policy Considerations -- Pendulum Swings in HIV-1 and Infant Feeding Policies: Now Halfway Back / Louise Kuhn and Grace Aldrovandi -- Should Women with HIV-1 Infection Breastfeed Their Infants? It Depends on the Setting / Grace John-Stewart and Ruth Nduati -- Part 7. The Epilogue -- The Future of Breastfeeding in the Face of HIV-1 Infection: Science and Policy / Marc Bulterys and Athena P. Kourtis.
    Also available: Print – 2012
  • 2014From: Springer Protocols
    edited by Elisa Vicenzi and Guido Poli.
    Virion attachment and entry : HIV gp120 env biotinylation, gp120 env, or integrin ligand-binding assay / Claudia Cicala and James Arthos -- CryoEM analysis of capsid assembly and structural changes upon interactions with a host restriction factor, TRIM5[alpha] / Gongpu Zhao and Peijun Zhang -- The fate of HIV-1 capsid : a biochemical assay for HIV-1 uncoating / Yang Yang, Jeremy Luban, and Felipe Diaz-Griffero -- The cyclosporin A washout assay to detect HIV-1 uncoating in infected cells / Amy E. Hulme and Thomas J. Hope -- Imaging HIV-1 nuclear pre-integration complexes / Anna Cereseto and Mauro Giacca -- HIV-1 reverse transcription / Andrea Cimarelli and Jean-Luc Darlix -- RNase H : specificity mechanisms of action, and antiviral target / Karin Moelling, Felix Broecker, and John E. Kerrigan -- HIV-1 chromatin, transcription, and the regulatory protein Tat / Laurence Colin, Eric Verdin, and Carine Van Lint -- HIV-1 Rev function and RNA nuclear-cytoplasmic export / Alan Cochrane -- HIV-1 accessory proteins : Nef / Anke Heigele [and three others] -- HIV-1 accessory proteins : VpR / Richard Y. Zho and Michael I. Bukrinsky -- HIV-1 accessory proteins : Vpu and Vif / Amy Andrew and Klaus Strebel -- SIVSM/HIV-2 Vpx proteins : function and uses in the infection of primary myeloid cells / Gregory Berger and Andrea Cimarelli -- Imaging of HIV assembly and release / Barbara Müller and Jacomine Krijnse-Locker -- HIV-1 isolation from infected peripheral blood mononuclear cells / Stefania Dispinseri [and four others] -- Determination of HIV-1 co-receptor usage / Mariangela Cavarelli and Gabriella Scarlatti -- The macrophage and HIV : basic concepts and methodologies / Suzanne Gartner -- HIV infection of dendritic cells / Najla Nasr [and three others] -- Histocultures (tissue explants) in human retrovirology / Anush Arakelyan [and four others] -- Single-copy quantification of HIV-1 in clinical samples / Ann Wiegand and Frank Maldarelli -- Quantification of total HIV1-DNA in peripheral blood mononuclear cells / Christine Rouzioux, Adeline Mélard, and Véronique Avéttand-Fénoël -- HIV-1 based lentiviral vectors / Ying Poi Liu and Ben Berkhout -- Quantification of miRNA by poly(A)-RT-qPCR arrays and verification of target sites in HIV-1 using a one-LTR infectious molecular clone / Zachary A. Klase, Laurent Houzet, and Kuan-Teh Jeang -- Investigating human T cell lymphotropic retrovirus (HTLV) Tax function with molecular and immunophenotypic techniques / Greta Forlani, Roberto S. Accolla, and Giovanna Tosi -- Proviral load determination of HTLV-1 and HTLV-2 in patients' peripheral blood mononuclear cells by real-time PCR / Claudio Casoli, Elisabetta Pilotti, and Umberto Bertazzoni -- Quantitative analysis of human T-lymphotropic virus type 1 (HTLV-1) gene expression using nucleo-cytoplasmic fractionation and splice junction-specific real-time RT-PCR (qRT-PCR) / Ilaria Cavallari, Francesca Rende, and Vincenzo Ciminale.
  • 2006From: Springer
    edited by Herman Friedman, Steven Specter, Mauro Bendinelli.
  • 2014From: Springer
    Scott D. Rhodes, editor.
    HIV continues to be a profound challenge facing communities nationally and internationally. Until a vaccine or a cure is found, prevention remains a most crucial line of defense. However, the successes made to reduce exposure and transmission have not benefited all communities equally. HIV continues to affect vulnerable communities, and HIV-related health disparities are growing. The work documented in Innovations in HIV Prevention Research and Practice through Community Engagement spotlights the effectiveness of community involvement to reduce HIV infections in the United States. This timely resource introduces the concepts of community engagement, partnership, and community-based participatory research (CBPR). Contributors provide detailed examples of these concepts in which diverse research partners blend their unique insights and skills to arrive at an authentic understanding of phenomena and inform the translation of best practices and processes to enhance equity in HIV prevention and treatment. Equitable interactive collaboration is central to these efforts, in which community members and representatives from organizations, the scientific and medical sectors, and other relevant agencies nurture long-term health improvement through sustained teamwork. Challenges and barriers to effective engagement are identified, as are characteristics of successful partnerships. Included in the book: Details of a multigenerational HIV prevention intervention in a rural southeastern community. The challenges and successes of developing, implementing, and evaluating an intervention for higher-risk predominately heterosexual black men in college. The history of gay community involvement in HIV prevention and its contributions to the theory and current practice of engagement. Next steps in the integration of HIV-related policy change and research. Community engagement within American Indian communities. Keys to sustaining a CBPR partnership to prevent HIV within ethnic, sexual, and gender minority communities. Innovations in HIV Prevention Research and Practice through Community Engagement offers researchers and practitioners in public health, community health, and medicine guidance on community engagement that is both inspiring and realistic. 'Community engagement and knowledge continue to be essential to prevent HIV infections. This book is a compilation of the state-of-the-science of engagement and delves deeper into the meaning and utilization of community-based participatory research, with implications that reach beyond the HIV epidemic to public health and medicine in general.' - Laura C. Leviton, PhD, Senior Advisor for Evaluation, Robert Wood Johnson Foundation, Princeton, NJ
  • Charlotte DeCroes Jacobs.
    PrintStatus: Not Checked OutLane Catalog Record
    "He first full biography of Jonas Salk offers a complete picture of the enigmatic figure, from his early years working on an influenza vaccine--for which he never fully got credit--to his seminal creation of the Polio vaccine, up through his later work to find a cure for AIDS"-- Provided by publisher.
  • 2013From: ProQuest Ebook Central
    Lesley Doyal with Len Doyal.
  • 2013From: Springer
    Peter H.C. Lim, editor.
    Men's Health is a concise, didactic compendium that covers three important aspects of male sexual health:- Testosterone Deficiency Syndrome; Premature Ejaculation and Sexually Transmitted Infections (STIs).The chapters that deal with Testosterone Deficiency Syndrome cover the epidemiology of the condition in the local context, the science behind the condition, its clinical presentation and treatment choices.The section on Premature Ejaculation advises the health practitioner on how to investigate this condition and describes the various treatment options available to the patient.The chapters on Sexually Transmitted Infections cover special aspects of the diagnosis, prevention and treatment of STIs occurring in Men which are not normally highlighted in the usual texts on STI management.Written by experts in the field, Men's Health is a valuable and timely resource for urologists, andrologists, endocrinologists as well as other health professionals practicing in these areas.
  • 2008From: NAP
    Committee on the Methodological Challenges in HIV Prevention Trials, Board on Global Health, Institute of Medicine of the National Academies ; Stephen W. Lagakos and Alicia R. Gable, editors.
    "This IOM committee was formed at the request of the Bill & Melinda Gates Foundation and charged with addressing methodological challenges in late-stage nonvaccine biomedical HIV prevention trials with a specific focus on microbicide and pre-exposure prophylaxis trials."
  • 2014From: Springer
    Jeremy Nuttall, editor.
    One of the most promising new approaches for the prevention of HIV transmission, particularly for developing countries, involves topical, self-administered products known as microbicides. The development of microbicides is a long and complicated process, and this volume provides an overview of all the critical areas, from the selection of appropriate candidate molecules and their formulation, preclinical and clinical testing for safety and efficacy, strategies for product registration and finally, issues associated with product launch, distribution and access. The book will prove valuable to both those working in the field and all others who are interested in learning more about this product class, which has the potential to significantly impact the future of this devastating epidemic.
  • 2011From: ScienceDirect
    edited by Gianfranco Pancino, Guido Silvestri, Keith R. Fowke.
    Natural SIV infection : virological aspects / Jan Münch and Frank Kirchhoff -- Natural SIV infection : immunological aspects / Béatrice Jacquelin, Roland C. Zahn, Françoise Barré-Sinoussi, Jörn E. Schmitz, Amitinder Kaur and Michaela C. Müller-Trutwin -- Implications for therapy / Ivona Pandrea and Alan L. Landay -- Are some people protected against HIV infection? / Mario Clerici, Mara Biasin and Gene M. Shearer -- The genital mucosa, the front lines in the defense against HIV / T. Blake Ball and Kristina Broliden -- Host genetics and resistance to HIV-1 infection / Ma Luo, Paul J. McLaren and Francis A. Plummer -- The immune system and resisting HIV infection / Keith R. Fowke, Catherine M. Card and Rupert Kaul -- Definition, natural history and heterogeneity of HIV controllers / Asier Sáez-Cirión, Gianfranco Pancino and Olivier Lambotte, for the ANRS CO18 Cohort -- Residual viremia and viral reservoirs in elite controllers / Robert W. Buckheit III and Joel N. Blankson -- Immune responses associated to viral control / Florencia Pereyra and Bruce D. Walker -- Immune mechanisms of viral control in HIV-2 infection / Eirini Moysi, Thushan de Silva and Sarah Rowland-Jones -- Genetic associations with resistance to HIV-1 infection, viral control and protection against disease / Jacques Fellay and Amalio Telenti.
  • 2016From: OSO
    Anne Esacove.
    Tracing the story of AIDS: an introduction to narrative, "African" AIDS and the U.S. prevention response -- Embodied risk: gender, modernity, & tradition -- Love matches: the policy prescription for "good" sex -- The sweetest sex possible...under the circumstances: the everyday prescription for "good" sex -- Prevention strategies: individualized & bureaucratic practices for creating modern actors -- Renarrating good sex: redirecting prevention.
  • 2010From: Springer
    Dirk P. Dittmer, Susan E. Krown, editors.
    Cancer incidences increase in people living with HIV/AIDS. Over 2 million people currently live with HIV/AIDS in the US. This number will increase as HAART prolongs the average lifespan and as (at least in some states) the number of new HIV infections increase again. As this population ages their incidence rates for cancer will increase, as well. Recently, new rational targets for cancer therapy have emerged. But their application to the care of HIV+ patients is slow, because of concerns about the weakened immune status of the patients, because of possible drug interactions with HAART and because some of the AIDS defining cancer are rare.
  • 2010From: WHO
    Also available: Print – 2010
  • v. 1-3, 2008-2010.From: Springer
    v. 2, 2009From: Springer
    v. 3, 2010From: Springer
    edited by Vassil St. Georgiev, Karl A. Western, John J. McGowan.
    v. 1. Frontiers in research -- v. 2. Impact on Global Health -- v. 3. Intramural research.
  • 2014From: ScienceDirect
    edited by Aftab A. Ansari, Guido Silvestri.
  • 2014From: ScienceDirect
    edited by Alex C. Tselis and John Booss.
    This volume in the Handbook of Clinical Neurology series provides a complete review of the history, science and current state of neurovirology. It covers the science and clinical presentation, diagnosis, and treatment of viruses of the brain and central nervous system, and is a trusted resource for scholars, scientists, neuroscientists, neurologists, virologists, and pharmacologists working on neurovirology. Neurovirology has been significantly bolstered by modern technologies such as PCR and MRI with direct impact on isolating viruses and advancing therapeutics based on molecular medicine. These advances are particularly important today with the introduction of emerging and re-emerging diseases such as HIV/AIDS, Nipah encephalitis and the appearance of West Nile encephalitis in the western hemisphere.
  • 2013From: Springer
    Sevgi O. Aral, Kevin A. Fenton, Judith A. Lipshutz, editors.
    Socio-demographic societal and supra-societal determinants and influences -- Social determinants of sexual networks, partnership formation, and sexually transmitted infections -- Epidemiology of STI and HIV: an overview of concentration and geographical and temporal dispersion -- Migration and the transmission of STIs -- Sexual networks and sexually transmitted infections: the strength of weak (long distance) ties -- Personal risk and public impact: balancing individual rights with STD and HIV prevention -- Critical factors in approaches to prevention -- Distribution of prevention resources and impact of sexual health in the USA -- Scaling up, coverage, and targeting -- Electronic media and STI prevention -- Twenty-first century leadership for public health and HIV/STI prevention -- Critical reveiws: enw public health focus for populations at risk for STI/HIV -- Enhancing women's sexual health: prevention measures in diverse populations of women -- Prevention of HIV and other blood-borne and sexually transmitted diseases in people who inject drugs: current status and future prospects -- Health, seuxal health, and syndemicsL toward a better appraoch to STI and HIV preventive interventions for men who have sex with men (MSM) in the United States -- Social determinants of sexual health in the USA among racial and ethnic minorities -- Adolescent sexual health and sexually transmitted infections: a conceptual and empirical demonstration -- Critical reviews: new public health STD/HIV prevention -- Preventing HIV/AIDS in the United States, 1981-2009: history in the making -- National strategic approach to improving the health of gay and bisexual men: experience in Australia -- Reducing disparities in sexual health: lessons learned from the campaign to eliminate infectious syphilis from the United States -- Human papillomavirus vaccine and prevention of human papillomavirus-associated disease in the USA -- Chlamydia control: a comparative reveiw from the USA and UK.
  • by Edward C. Klatt.
  • 2009From: Springer
    by Amy Nunn.
  • PEPFAR, first authorized in 2003, has supported significant advances in HIV/AIDS prevention, treatment, and care in over 30 countries, including directly supporting treatment for about 5.1 million people; however, millions more people still need treatment. PEPFAR has allocated more than half of its funding to care and treatment and has spent over $1.2 billion to purchase ARV drugs. In addition to supplying ARV drugs directly in some countries, PEPFAR also helps partner countries manage their drug supply chains. GAO was asked to review PEPFAR supported ARV drug supply chains. GAO examined (1) actions PEPFAR has taken regarding ARV drug supply chains and (2) partner-country ARV drug supply chain operations. GAO reviewed PEPFAR and the U.S. Agency for International Development (USAID) guidance and supply chain studies; analyzed 16 supply chain evaluations conducted in seven countries and published in 2011 and 2012; interviewed officials from OGAC, USAID, and other agencies; and conducted fieldwork in three countries selected on the basis of program size and other factors.
  • editors, Mamatha M Lala, Rashid H Merchant ; forewords, Hoosen Coovadia, Ishwar S Gilada, Janak K Maniar.
    PrintStatus: Not Checked OutLane Catalog Record
  • 2006From: Ovid
    [edited by] Francisco Fernandez, Pedro Ruiz.
    Epidemiology / Margarita Alegría ... [et al.] -- Virology, immunology, transmission, and disease stage / Karl Goodkin -- Medical treatment and occupational exposure / Ellen A.B. Morrison, Jon A. Levenso -- Psychiatric assessment / María Fernanda Gómez, Mary Alice O'Dowd -- Psychological and neuropsychological testing / Joel K. Levy -- Electrophysiology and brain mapping / Harold W. Goforth, Lukasz M. Konopka -- Psychological reactions / Vicenzio Holder-Perkins, Jeffrey S. Akman -- Stress-distress spectrum and adjustment disorders / Dimitri D. Markov, Elisabeth J.S. Kunkel, Howard Field -- Anxiety disorders / Annette M. Matthews, Manuel Trujillo -- Mood disorders / Pedro Ruiz -- Personality disorders / Khenu Singh, Herb Ochitill -- Cognitive disorders / Angela M. McBride, Francisco Fernandez -- Psychotic disorders / Ewald Horwath, Francine Cournos -- Substance use disorders / Stephen J. Ferrando, Steven L. Batki -- Sleep disorders / Carlos A. Santana, Francisco Fernandez -- Psychotropic drug interactions with antiretroviral medications / Philip A. Bialer, Kyle S. Kato, Vassilios Latoussakis -- Pain syndromes / William Breitbart -- Sexually transmitted infections / Angela L. Stotts ... [et al.] -- Psychiatric comorbidities in medically ill patients with HIV/AIDS / Stephen J. Ferrando, Constantine G. Lyketsos -- HIV/AIDS among Hispanic Americans / Pedro Ruiz, Frank Fernandez -- HIV/AIDS among African Americans / William B. Lawson, Janice G. Hutchinson, Dianne L. Reynolds -- HIV/AIDS among Asian and Pacific Islander Americans / Lynette J. Menezes, Todd Wills, Karina D'Souza -- HIV/AIDS among American Indians and Alaska natives / Carol E. Kaufman ... [et al.] -- HIV/AIDS among neonates and infant / Andrea Stolar, Johanna Goldfarb -- HIV/AIDS among children and adolescents / Andres J. Pumariega, Margaret A. Shugart, JoAnne B. Pumariega -- HIV/AIDS among older adults / Maria D. Llorente, Julie E. Malphurs -- HIV/AIDS among women / Isabel T. Lagomasino, Gustavo Rodriguez -- HIV/AIDS among men who have sex with men / Milton L. Wainberg, Kenneth B. Ashley -- HIV/AIDS among women who have sex with women / Alison R. Jones, Cynthia L. Hoyler -- HIV/AIDS among the homeless / Jacqueline Maus Feldman, Stephen M. Goldfinger -- HIV/AIDS among prisoners / Wade C. Myers ... [et al.] -- HIV/AIDS and the patient's family / James L. Griffith, Michael Golder -- Ethical, forensic, and legal considerations / James Satriano -- Religious and spiritual considerations / Daniel W. Hicks, Francis G. Lu -- Psychotherapeutic strategies / Claire Zilber -- Complementary and holistic medicine / Janet Konefal, Jessica Lillisand -- Biopsychosocial aspects / Cheryl Gore-Felton, Cheryl Koopman, David Spiegel -- Suicide and end-of-life care / Mary Ann Cohen -- Prevention and education strategies / Michael D. Knox, Tiffany Chenneville -- Physician assisted suicide and voluntary euthanasia / Marshall Forstein.
  • 2014From: Springer
    Li, Hongjun.
    Molecular Biology of HIV/AIDS and Its Clinical Management -- An Overview of Clinical Immunology of HIV/AIDS -- An Overview of Clinical Microbiology of HIV/AIDS -- Epidemiological Investigation of AIDS -- Pathogenetic and Pathological Mechanism -- Clinical Manifestations of HIV/AIDS Infection -- Laboratory Test and Special Examinations -- Diagnostic Imaging -- AIDS Imaging and Evidence Based Medicine -- Clinical Medication Against HIV/AIDS -- Introduction to Assessment and Monitoring of Critical AIDS -- HIV Related Effect Factors -- HIV/AIDS Related Nervous System Diseases -- HIV/AIDS Related Myeleterosisand Peripheral Neuropathy -- HIV/AIDS Related Eye Diseases -- HIV/AIDS Related Neck Diseases -- HIV/AIDS Related Respiratory Diseases -- HIV/AIDS Related Cardiac Diseases -- HIV/AIDS Related Gastrointestinal Diseases -- HIV/AIDS Related Hepatobiliary, Pancreatic and Splenic Diseases -- HIV/AIDS Related Peritoneal and Retroperitoneal Disease -- HIV/AIDS Related Urogenital Disease -- HIV/AIDS Related Musculoskeletal Diseases -- HIV/AIDS Related Pediatric Diseases -- HIV/AIDS Related Skin Diseases -- Functional Imaging of HIV/AIDS.
  • 2006From: Springer
    edited by Gail Skowron, Richard Ogden ; foreword by Joep M.A. Lange.
    Structural studies on HIV reverse transcriptase related to drug discovery / David K. Stammers and Jingshan Ren -- Zidovudine, lamivudine, and abacavir / Monica Carten and Harold Kessler -- Stavudine, didanosine, and zalcitabine / Gail Skowron, Sapna Chowdhry and Michael R. Stevens -- Emtricitabine / Gail Skowron, Jeffrey Bratberg and Rudi Pauwels -- Nucleotide analogs / Craig J. Hoesley -- Resistance to nucleoside and nucleotide reverse transcriptase inhibitors / Nancy Shulman and Mark Winters -- Pharmacokinetics of reverse transcriptase inhibitors / Patrick Hoggard ... [et al.] -- Peripheral neuropathy associated with nucleoside reverse transcriptase inhibitor therapy / Bruce A. Cohen and Russell Bartt -- Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: a pathophysiological perspective / William Lewis -- Mitochondrial toxicity and lipodystrophy / Grace McComsey -- Nevirapine / David Asmuth and Richard Pollard -- Efavirenz / Graeme J. Moyle and Brian Conway -- Delavirdine / Brian Conway -- Resistance to non-nucleoside reverse transcriptase inhibitors / F. Ramzi Asfour and Richard Haubrich -- Vertical transmission of HIV and therapeutic interventions / Susan Cu-Uvin, Arlene Bardeguez and Carla Chibwesha -- New reverse transcriptase inhibitors in development / Rudi Pauwels -- Antiretroviral drugs for millions / Allan Ronald, Ellie Katabira and Merle Sande.
  • 2012From: ClinicalKey
    [edited by] Paul A. Volberding [and others].
    Access the latest information available in the challenging area of HIV/AIDS management with Sande's HIV/AIDS Medicine, 2nd Edition. Authored by a veritable "who's who" of current global experts in the field, this medical reference book will provide you with all the practical, indispensable guidance you'll need to offer your patients the best possible care.Access reliable, up-to-the-minute guidance that addresses the realities of HIV/AIDS management in your geographical region, thanks to contributions from a global cast of renowned expert clinicians and researchers. Locate the clinically actionable information you need quickly with an organization that mirrors the current state of the AIDS epidemic and the different needs of Western vs. developing-world patients and clinicians. Diagnose AIDS manifestations confidently by comparing them to full-color clinical images. Improve patient outcomes with the latest findings on the management of AIDS as a chronic illness. Efficiently review essential data through numerous at-a-glance tables. Get the most relevant information available on pediatric HIV and AIDS issues; anti-retroviral drugs, including integrase inhibitors; and the use of second- and third-line anti-retroviral drugs in resource-poor settings. Stay current on the latest actionable information, such as using antiretroviral therapy in patients with tuberculosis and drug-resistant tuberculosis; antiretroviral therapy; immune reconstitution inflammatory syndromes (IRIS); and implementation of the HPV vaccine. The very latest in HIV/AIDS management from global experts with a concise approach and a clinical/practical focus.
  • 2012From: CRCnetBASE
    editors, Colin R. Martin, Victor R. Preedy.
    HIV/AIDS : an overview / Francis Agyemang-Yeboah and Bernard C. Nkum -- Can teens teach other teens HIV prevention? : implications for AIDS and pregnancy / Ganga Mahat and Maryann Scoloveno -- Knowledge of antenatal attendees about HIV/AIDS in pregnancy / Anietie Effiong Moses, Emem Abasi Bassey, and Godwin Etim Asuquo -- Midwives and occupational exposures to HIV / Maria Ganczak -- Pregnancy and delivery in HIV positive women : antenatal care and outcome / Karoline Aebi-Popp, Christoph Rudin, and Luigia Elzi -- Management of HIV/AIDS stigma : nursing perspectives / Susan W. Gaskins -- Prenatal assistance to pregnant women with HIV/AIDS / Prescilla Chow ... [et al.] -- Antenatal screening and HIV-pregnancy : strategies for treatment / Ali A. Al-Jabri ... [et al.] -- Low lymphocyte count in HIV-pregnancy and strategies for treatment / Alashle Abimiku and Evaezi Okpokoro -- Antiretroviral regimens recommended for prevention of mother-to-child transmission of HIV / Christiana Smith and Adriana Weinberg -- Pregnancy-related adverse effects of antiretroviral therapy / Elie Azria, Sophie Matheron, and Dominique Luton.
  • To serve as a tool to help community planning groups (CPGs), health departments, and other stakeholders understand the issues behind Latino participation in HIV prevention community planning, as well as to increase Latino participation in the process.
  • 2013From: Springer
    W. David Wick, Otto O. Yang.
    In the relatively few decades since the introduction of HIV into the human population, variants of the virus have diverged to such an extent that, were the discussion about something other than viruses, said variants could easily be classified as different species. This book will consider these evolutionary variations, as well as the different and, at times, opposing theories attempting to explain them. It will compare and contrast the ways in which the immune system and drugs affect the virus's evolution, and the implications of these for vaccine development. The issue will be explored and explained through "ecological genetics," which postulates that all living organisms have, besides rivals, enemies. This is divergent from the more traditional school of "population genetics," which emphasizes that evolution occurs among rival species (or variants thereof) that compete for niches or resources in a fixed, unreactive environment. Both models will be formulated using mathematical models, which will be included in the book. Finally, it will consider the possibilities for designing a vaccine that blocks HIV from escaping the immune system.

Access restricted to Stanford community

Shortcut to Licensed Content

Lane Gateway to Licensed Content

TO INSTALL, DRAG THIS BUTTON to your browser Bookmarks or Tools Bar.

What is it?

Lane Gateway to Licensed Content

Bookmark on Other Websites

Bookmark on Lane

  • TO INSTALL, RIGHT CLICK this button.
  • Select "Add to Favorites" (click “Continue” if you see a security alert)
  • From the "Create in" menu, select “Favorites Bar” (IE8, IE9) to install
  • Once installed it will look like this
  • Click "Bookmark on Lane" to bookmark any webpage
  • Your saved bookmark will appear on this page

What is it?

Derived from Current Medical Diagnosis & Treatment, AccessMedicine's Quick Medical Diagnosis & Treatment provides topic reviews with key diagnostic and treatment features for more than 500 diseases.

A repository of medical knowledge from internal medicine, cardiology, genetics, pharmacy, diagnosis and management, basic sciences, patient care, and more.

Continuously expanding, all databases in the repository contain the latest editions of selected medical titles.

MicroMedex: Premier pharmaceutical information source containing multiple databases and drug reference tools. Of particular value is DRUGDEX Evaluations, one of the most comprehensive drug sources available.DynaMed Plus is a clinical information resource used to answer questions quickly at the point-of-care. Easy-to-interpret Levels of Evidence help clinicians rapidly determine the quality of the available evidence.

Biomedical and pharmacological abstracting and indexing database of published literature, by Elsevier. Embase® contains over 32 million records from over 8,500 currently published journals (1947-present) and is noteworthy for its extensive coverage of the international pharmaceutical and alternative/complementary medicine literature.

Scopus is the largest abstract and citation database of peer-reviewed literature: scientific journals, books and conference proceedings.A drug information resource containing: American Hospital Formulary System (AHFS), drug formulary for Lucile Packard Children's Hospital (LPCH) and Stanford Hospital & Clinics (SHC), Lexi-Drugs (adverse reactions, dosage and administration, mechanism of action, storage, use, and administration information), Lexi-Calc, Lexi-ID, Lexi-I.V. Compatibility (King Guide), Lexi-Interact, and Lexi-PALS.Cumulative Index to Nursing and Allied Health Literature (CINAHL) contains coverage of nursing and allied health literature.A knowledge database that provides access to topic reviews based on over 6000 clinically relevant articles. The evidence-based content, updated regularly, provides the latest practice guidelines in 59 medical specialties.Provides critical assessments of systematic reviews compiled from a variety of medical journals.Selects from the biomedical literature original studies and systematic reviews that are immediately clinically relevant and then summarizes these articles in an enhanced abstract with expert commentary.

Multidisciplinary coverage of over 10,000 high-impact journals in the sciences, social sciences, and arts and humanities, as well as international proceedings coverage for over 120,000 conferences.

Includes cited reference searching, citation maps, and an analyze tool.

Features systematic reviews that summarize the effects of interventions and makes a determination whether the intervention is efficacious or not.

Cochrane reviews are created through a strict process of compiling and analyzing data from multiple randomized control trials to ensure comprehensiveness and reliability.

Provides systematic coverage of the psychological literature from the 1800s to the present through articles, book chapters and dissertations.BMJ Clinical Evidence. A clinical information tool built around systematic reviews summarizing the current state of knowledge about prevention and treatment of clinical conditions.PIER (Physicians' Information and Education Resource) is a Web-based decision-support tool designed for rapid point-of-care delivery of up-to-date, evidence-based guidance for primary care physicians.Cochrane Central Register of Controlled Trials (CENTRAL) provides access to 300,000 controlled trials that have been identified the Cochrane Collaboration.Provides drug information targeted for patients.A continually updating drug monograph.The National Guideline Clearinghouse (NGC): A comprehensive database of evidence-based clinical practice guidelines and related documents.MedlinePlus: A repository of health information from the National Library of Medicine. Links are from trusted sites. No advertising, no endorsement of commercial companies or productsLPCH CareNotes via MicroMedex: Patient education handouts customized by LPCH clinical staffMicromedex Lab Advisor: Evidence based laboratory test informationA drug database organized by generic name, trade name and drug class.LPCH / Stanford Hospital Formulary.A goldmine of trusted consumer health information from the world's largest medical library.A trusted source of expert advice for and about kids, providing the information necessary to help patients and parents understand their unique needs.Provides patient handouts from the American Academy of Family Physician.Access to the Stanford Health Library for patients.Lane provides access to over 5,000 eBooks many of which provide helpful background material that will prepare you to better tackle primary literature.

Largest, broadest eBook package; covers all sciences, as well as technology (including software), medicine, and humanities.

In addition to covering Wiley and Springer, MyiLibrary is also the only provider for Oxford and Cambridge University Press titles. No seat restrictions.

A collection of biomedical books that can be searched directly by concept, and linked to terms in PubMed abstracts.

A web-based, decision support system for infectious diseases, epidemiology, microbiology and antimicrobial chemotherapy. The database, updated weekly, currently includes 337 diseases, 224 countries, 1,147 microbial taxa and 306 antibacterial (-fungal, -parasitic, -viral) agents and vaccines.

Over 10,000 notes outline the status of specific infections within each country.

Large number of high quality software and database programming titles from O'Reilly. Other software titles are also available from Sams and Prentice Hall. Limited to 7 concurrent users.Vast collection of software and database programming titles from multiple publishers, including Microsoft Press.Largest provider of engineering-related eBooks; includes titles in computer science and biomedical engineering.Over 4,000 full-text e-books covering scientific and technical information from CRC Press and others. Many handbooks and single volume reference sources.Includes peer-reviewed life science and biomedical research protocols compiled from Methods in Molecular Biology, Methods in Molecular Medicine, Methods in Biotechnology, Methods in Pharmacology and Toxicology, Neuromethods, the Biomethods Handbook, the Proteomics Handbook, and Springer Laboratory Manuals.Contains full text access to selected biomedical and nursing books.

Provides online, full-text access to Springer's journal titles as well as journals from other publishers.

Subjects include: life sciences, chemical sciences, environmental sciences, geosciences, computer science, mathematics, medicine, physics and astronomy, engineering and economics. Also includes eBooks.

Collection of over 8 thousand fulltext titles in engineering, math, and basic and applied biomedical research. Coverage is from 1967 to the present.A library of ebooks on a wide array of topics, digitized and made available online in conjunction with the original publishers.

Stanford Medicine

Lane Medical Library